Clinical Trial Update: Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

View source ↗

Summary

Extended follow-up results from the Costa Rica Vaccine Trial (ESCUDDO-CVT) evaluating outcomes after one, two, or three doses of the HPV vaccine. The study asse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-related Malignant Neoplasms
• Human Papillomavirus Infection

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Human Papillomavirus Infection, Human Papillomavirus-Related Malignant Neoplasm | Status: ACTIVE_NOT_RECRUITING